A Study in Pediatric Patients With Cystic Fibrosis Lung Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and effectiveness of two dose
strengths of study drug compared to placebo in pediatric patients with cystic fibrosis (CF).